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Abstract: Functional protein analysis often calls for lengthy, laborious in vivo protein expression and purification, and can be   complicated 
by the lack of stability of the purified protein. In this study, we demonstrate the feasibility of a simplified procedure for functional   protein 
analysis on magnetic particles using cell-free protein synthesis of the catalytic subunit of human cAMP-dependent protein kinase as 
a HaloTag® fusion protein. The cell-free protein synthesis systems provide quick access to the protein of interest, while the HaloTag 
technology provides efficient, covalent protein immobilization of the fusion protein, eliminating the need for further protein purification 
and minimizing storage-related stability issues. The immobilized cPKA fusion protein is assayed directly on magnetic beads and can 
be used in inhibitor analyses. The combination of rapid protein synthesis and capture technologies can greatly facilitate the process of 
protein expression and activity screening, and therefore, can become a valuable tool for functional proteomics studies.
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Introduction
The field of proteomics requires protein expression 
for structural and functional studies. Cell-free protein 
expression systems, also known as in vitro translation 
systems, are alternatives to cell-based protein expres-
sion methods. The advantages of cell-free approaches 
include (1) no requirement for cell culture making 
them faster and easier to use, (2) the ability to express 
proteins that are difficult or toxic to express in cell 
culture, and (3) an open format that allows for the 
addition of auxiliary components such as labels that 
can facilitate downstream detection or applications 
such as structural analyses. They are amenable to the 
synthesis of many proteins in parallel allowing for the 
quick screening of constructs for protein expression. 
Also, any storage-related stability issues can be mini-
mized by synthesizing the target protein immediately 
prior to analysis.
The  most  commonly  used  cell-free  extracts  are 
based  on  rabbit  reticulocytes  and  E.  coli  extracts. 
Additionally,  extracts  made  from  wheat  germ  and 
insect cells are also commercially available. Some 
extracts function purely as translation systems and 
require the addition of RNA templates. Other extracts 
contain components for transcription, permitting the 
reactions to begin when a DNA template is   present. 
These  coupled  transcription/translation  systems 
(TNT® systems) eliminate the need to produce and 
purify  RNA,  further  simplifying  and  speeding  the 
cell-free protein expression process.
In vitro translation systems have been used to 
study protein function, especially to map domains 
involved  in  protein-protein  interactions1.  In  this 
study we wanted to show the feasibility of using 
cell-free  extracts  to  study  enzymatically  active 
proteins. We chose a human kinase, the catalytic 
subunit of human cAMP-dependent protein kinase 
(cPKA),  as  our  model  protein.  PKA  was  chosen 
because  sensitive  PKA  activity  assays,  known 
inhibitors  and  purified  recombinant  PKA,  which 
could be used as a positive activity control, were 
obtainable.
Four  commercially  available  cell-free  extracts 
were used for cPKA protein expression and then com-
pared with respect to expression levels and activity. 
These were the TNT® T7 Quick Coupled Transcrip-
tion/Translation System based on rabbit reticulocyte 
lysates  (RR),1,2  the  TNT®  SP6  High-Yield  Protein 
Expression System made from wheat germ embryo 
extracts  (WG),3,4  the TNT® T7  Insect  Cell  Extract 
Protein Expression System prepared from lysates of 
Sf21 cells (ICE)5,6 and the bacterial S30 T7 High-
Yield Protein Expression System (S30).7
To  capture  cPKA  from  the  protein  translation 
reaction, it was expressed as a fusion protein con-
taining a purification tag. The HaloTag® Technology 
was chosen for this purpose because it enables rapid, 
specific, covalent and oriented binding of HaloTag 
fusion  protein  to  solid  surfaces.8,9  The  HaloTag 
protein  is  a  genetically  engineered  version  of  a 
  hydrolase  enzyme.  The  modified  protein  forms  a 
covalent bond with its substrate, enabling protein 
labeling  or  immobilization  when  the  substrate  is 
attached to a label, such as a fluorophore, or solid 
surface,  respectively.  Therefore,  when  HaloTag 
protein (MW 34 kDa) is used as a fusion tag, the 
fusion protein can be labeled or captured. Vectors 
containing the HaloTag coding region and specifi-
cally designed for cell-free expression were used to 
express the cPKA fusion proteins.
In this study cPKA fusion protein was expressed in 
cell free reactions, monitored for detection levels, cap-
tured directly from the cell-free expression reaction and 
tested for activity (Fig. 1). The kinase was active and 
inhibited by known inhibitors. cPKA- HaloTag fusion 
protein expressed in wheat germ extracts has previ-
ously been shown to be functional.9 In this instance the 
kinase was assayed after covalent capture onto glass 
slides that had been   activated with ligand specific for 
the HaloTag moiety.9 The   present study expands this 
finding by comparing the expression and activity of 
cPKA in multiple cell-free extracts and examining 
its ability to be inhibited by known PKA inhibitors 
while attached to magnetic particles. The HaloTag 
technology  has  also  been  used  for  the  functional 
immobilization of another kinase, a plant receptor-
like kinase, for the purposes of ligand   identification.10 
The HaloTag fusion of the plant   receptor-like kinase, 
expressed in tobacco cells and captured on HaloLink 
resin, was shown to be active and useful for moni-
toring  ligand-receptor    interactions.10  As  cell-free 
systems are able to rapidly produce proteins in com-
parison to other protein expression methods, they are 
useful for rapid screening of multiple proteins. Iffland 
et al used in vitro translation in wheat germ extracts 
to  produce    multiple    phosphodiesterase  active  site  Cell-Free kinase
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mutants.11 The   His6-tagged mutants were captured on 
nickel-  chelating resin and characterized in   enzymatic 
assays.11  Together  these  studies    demonstrate  the 
  usefulness  of  combining  cell-free  synthesis  meth-
ods,  for  rapid  functional  protein  production,  with 
  immobilization   technologies, to   eliminate the need 
for lengthy   purification, when conducting enzymatic 
  activity assays.
Materials and Methods
DnA template preparation
The catalytic subunit of human cAMP-dependent 
protein  kinase  (cPKA;  NM_002730)  was  cloned 
into  vectors  designed  for  expression  in  cell-free 
systems (Fig. 2; Promega, Madison, WI, USA). The 
cloning vectors used were pFN19K and pFC20K 
(HaloTag)  T7  SP6  Flexi®  Vectors  for  expression 
in the RR and WG systems; pFN18 K (HaloTag) 
T7  Flexi  Vector  was  used  for  expression  in  the 
S30 system. These vectors have the HaloTag cod-
ing sequences at the amino-  terminus (pFN18 and 
pFN19)  or  at  the  carboxy-  terminus  (pFC20)  of 
the  target  protein  insertion  site.  For  expression 
in the ICE system, derivatives of the pF25K ICE 
T7  Flexi  Vector  (Promega,  Madison,  WI,  USA) 
were  constructed  with  the  HaloTag  gene  at  the 
amino-   terminus or carboxy-terminus. The pF25K 
vector has untranslated regions from the baculovi-
rus polyhedrin gene at the 5’ and 3’ ends of the tran-
scriptional unit to enhance translational efficiency 
specifically in the insect cell extract.5,12 The Flexi 
System was used for cloning (Promega, Madison, 
WI, USA).13,14 The plasmid templates were purified 
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Figure 1. schematic of the Protein Analysis Process. Cell-free expres-
sion of the cPKA fusion protein was confirmed by western blot analysis 
and binding to a fluorescent HaloTag ligand. Kinase activity was mea-
sured after immobilization from cell-free reactions in the presence and 
absence  of  cPKA  inhibitors.  The  “bead”  in  the  figure  represents  the 
haloLink magnetic resin and the “hT” refers to the haloTag protein at the 
amino-terminus of the cPKA protein.
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Figure 2. Features of Cell-Free Expression Vectors. The cPKA gene was cloned into Flexi Vectors specific for cell-free expression. All of the vectors pos-
sessed the haloTag gene to generate synthesis of a fusion protein with the tag at the n or C- terminus. elements depicted include the promoters for T7 
and sP6 polymerases (T7 and sP6), untranslated regions (UTrs) located at the 5’ and 3’ of the protein coding regions in pF25- derived vectors pF25 n 
hT and pF25 C hT, a synthetic poly(A) site and the T7 polymerase terminator sequence (T7t). pFn19 and pFC20 plasmids directed expression in rr and 
Wg. pF25 n hT and pF25 C hT templates were used with the ICe system, while s30 reactions used the pFn18 plasmid. The sequences are not drawn 
to scale.Leippe et al
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using  the  PureYield™  Plasmid  MidiPrep  System 
(Promega, Madison, WI, USA) followed by etha-
nol precipitation and resuspension in nuclease-free 
water.
Cell-free protein expression
Four  cell-free  systems  were  used  to  express  the 
cPKA fusion proteins. These were the TNT T7 Quick 
Coupled  Transcription/Translation  System  based 
on rabbit reticulocyte lysates (RR),1,2 the TNT SP6 
High-Yield  Protein  Expression  System  made  from 
wheat germ embryo extracts (WG),3,4 the TNT T7 
Insect Cell Extract Protein Expression System pre-
pared from lysates of Sf21 cells (ICE)5,6 and the bac-
terial S30 T7 High-Yield Protein Expression System 
(S30).7 All systems were from Promega, Madison, 
WI, USA. The TNT systems are eukaryotic coupled 
transcription/translation systems that are initiated by 
the addition of DNA templates. The prokaryotic S30 
product is also driven by DNA templates. The reac-
tions were assembled and incubated as recommended 
in the manufacturer’s instructions for each system. 
Larger 500 µl reactions were prepared and after incu-
bation, aliquoted and frozen at −70°C.
Immunoblot analysis
Protein synthesis was assessed using western blot 
analysis. One microliter of translation reaction was 
added to 9 µl of SDS loading buffer and loaded onto 
4%–20% Tris-Glycine SDS PAGE gels (Invitrogen, 
Carlsbad, CA, USA). The gels were transferred to 
PVDF paper using the iBlot™ Dry Blotting System 
(Invitrogen,  Carlsbad,  CA,  USA).  Protein  size 
standards included ProSieve® Color Protein Markers 
(Lonza, Rockland, ME, USA) and SeeBlue® Plus2 
Prestained  Standards  (Invitrogen,  Carlsbad,  CA, 
USA).  The  blots  were  blocked  in  TBST  (TBS 
with  0.05%  Tween  20)  with  3%  blot-qualified 
BSA (Promega, Madison, WI, USA). PKA expres-
sion  was  detected  using  anti-PKA  polyclonal 
antibody  (Millipore,  Billerica,  MA,  USA)  and 
an  anti-  HaloTag  polyclonal  antibody  (Promega, 
Madison, WI, USA). The secondary antibody was 
alkaline phosphatase conjugated donkey anti-rabbit 
(Promega, Madison, WI, USA). All antibodies were 
diluted in TBST for incubation with the PVDF mem-
branes. The membranes were rinsed with TBS before 
developing  with  the  colorimetric  reagent  Western 
Blue®   Stabilized Substrate for Alkaline Phosphatase 
(Promega,   Madison, WI, USA). Gels that were to be 
probed with the antibody to PKA also included a lane 
with a highly purified recombinant catalytic subunit 
of bovine PKA (Promega, Madison, WI, USA).
haloTag TMr ligand binding assay
The  HaloTag  Technology  enables  covalent  protein 
labeling and immobilization.8,9 In this case, a ligand 
containing a TMR fluorophore (HaloTag TMR Ligand; 
Promega,  Madison,  WI)  was  used  to  covalently 
label  the  HaloTag  fusion  proteins  synthesized  in 
the  translation  reactions.  Ten  microliters  of  each 
translation reaction was incubated with 5 µl of PBS 
and 5 µl of 50 µM TMR Ligand for 30 minutes at room 
temperature. Two microliters of the labeling reaction, 
equivalent to one microliter of the starting transla-
tion reaction, was mixed with SDS loading buffer 
and loaded onto a 4%–20% Tris-Glycine SDS PAGE 
gel (Invitrogen, Carlsbad, CA). After electrophoresis, 
the gel was imaged using the Typhoon Variable Mode 
Imager 9410 (GE Healthcare,   Piscataway, NJ) with a 
green laser (532 nm) and a 580BP30 emission filter. 
Data was processed using the program ImageQuant 
(GE  Healthcare,  Piscataway,  NJ).  For  concentra-
tion  estimates,  purified  recombinant  GST-HaloTag 
protein of known concentration was diluted in PBS, 
incubated with TMR Ligand for 30 minutes at room 
temperature, and used as a standard.
Immobilization on haloLink™  
magnetic beads
The  substrate  for  the  HaloTag  protein  has  also 
been linked to surfaces to covalently capture fusion 
proteins.8,9  HaloLink  Magnetic  Beads  (Promega, 
Madison, WI) were used to covalently capture the 
PKA fusion proteins out of the translation reactions. 
For immobilization, 100 µl of magnetic particle slurry 
were transferred to 1.5 ml microfuge tubes in a mag-
netic separation stand and washed three times with 
1 ml of wash buffer (TBS + 0.05% IgePal CA-630; 
Sigma Aldrich, St. Louis, MO) before final resuspen-
sion in 100 µl of the wash buffer. Fifty microliters of 
the protein synthesis reaction and an additional 50 µl 
of wash buffer were added to the magnetic particles, 
for a total volume for 200 µl. Immobilization was 
allowed to proceed for 30 minutes at room tempera-
ture with shaking (900 rpm in an orbital benchtop  Cell-Free kinase
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shaker). After  the  initial  incubation,  the  unbound 
material was collected and the particles were washed 
three times with 1 ml of wash buffer. The particles 
were then washed three times with 1 ml of kinase 
buffer, prepared by making a 1X dilution of the 5X 
Kinase  Buffer  provided  with  the  ProFluor®  PKA 
Assay (see below). The particles were resuspended 
in 200 µl of kinase buffer and immediately used in 
the kinase activity assay.
PKA activity assay and inhibitor test
The ProFluor PKA Assay system (Promega, Madison, 
WI) was used to assay for PKA kinase activity. The 
assay was essentially conducted following the pro-
tocol in the manufacturer’s technical manual. Three 
buffers were prepared: (1) 1X kinase buffer (40 mM 
Tris-HCl pH 7.5, 20 mM MgCl2, 0.1 mg/ml BSA), 
(2) reaction buffer (1X kinase buffer with 1 µl rho-
damine 110 peptide substrate and 10 µl 10 mM ATP 
per ml), and (3) termination buffer (40 mM Tris-HCl 
pH 7.5, 100 mM EDTA, 0.1 mg/ml BSA with 20 µl 
protease reagent per ml). Five to 25 µl of magnetic 
particles with immobilized PKA fusion protein cova-
lently attached were distributed into wells of a black 
96 well plate. Care was taken to make sure the parti-
cles in the 200 µl of kinase buffer were well dispersed 
before pipetting into wells. The volume in each well 
was adjusted to 25 µl as necessary with 1X kinase 
buffer. Twenty-five microliters of reaction buffer were 
then added, for a final ATP concentration of 50 µM 
in the activity reaction. The plate was covered and 
incubated for 20 minutes at room temperature with 
shaking (on a plate shaker at 600 rpm). Twenty five 
microliters of termination buffer were added. Again 
the plate was covered and incubated for 30 minutes at 
room temperature with shaking. The fluorescent sig-
nal was measured at excitation and emission wave-
lengths of 485 and 527 nm, respectively, using a plate 
fluorescence reader.
For the inhibitor test, 100 µM stocks were made 
in 10% DMSO or in 1X kinase buffer depending 
on individual solubility characteristics. The activ-
ity assay was conducted as above except that after 
pipetting  particles  into  the  well,  the  volume  was 
brought  to  only  20  µl  with  kinase  buffer.  Then 
5 µl of the 100 µM inhibitor stock was added to 
the particles bringing the final concentration of the 
inhibitor in the 50 µl kinase reaction to 10 µM. Con-
trols  lacking ATP,  to  prevent  kinase  activity  and 
therefore  determine  maximal  fluorescent  output, 
were also   performed in parallel. The highly puri-
fied   recombinant catalytic subunits of bovine PKA 
(Promega) and human PKA (Sigma) were used as 
positive controls. The kinase inhibitors were from 
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Figure 3. Protein Detection. A) Western Blot with anti-PKA antibody. One µl of each protein synthesis reaction was loaded per lane. The arrow points to 
the expressed cPKA fusion protein, which has a predicted molecular weight 74 kDa. Lane 1, MW markers; Lane 2, recombinant bovine heart PKA catalytic 
subunit; Lane 3, rr no DnA; Lane 4, rr pFn19; Lane 5, rr pFC20; Lane 6, ICe no DnA; Lane 7, ICe n-terminal fusion; Lane 8, ICe C-terminal fusion; 
Lane 9, Wg no DnA; Lane 10, Wg pFn19; Lane 11, Wg pFC20; Lane 12, s30 no DnA; Lane 13, s30 pFn18. Proteins of unknown identity were reproduc-
ibly detected by immunoblot in the s30 reaction (see Lane 12). B) Fluorimage of the fusion protein fluorescently labeled with HaloTag TMR ligand. Each 
lane contains the equivalent of 1 µl of protein expression reaction. The arrow points to the expressed cPKA fusion protein, which has a predicted molecular 
weight 74 kDa. Lanes 1 and 2, purified GST-HaloTag protein (MW 62 kDa); Lane 3, RR no DNA; Lane 4, RR pFN19; Lane 5, RR pFC20; Lane 6, ICE no 
DnA; Lane 7, ICe n-terminal fusion; Lane 8, ICe C-terminal fusion; Lane 9, Wg no DnA; Lane 10, Wg pFn19; Lane 11, Wg pFC20; Lane 12, s30 no 
DnA; Lane 13, s30 pFn18. Free, unbound haloTag TMr ligand is visible at the bottom of the gel.Leippe et al
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Promega  (Madison,  WI;  PKI  and  U0126),  Sigma 
Aldrich (St. Louis, MO; Staurosporine) and EMD 
(San Diego, CA; all other inhibitors).
Results
Protein expression and levels
The  catalytic  subunit  of  human  cAMP-dependent 
protein  kinase  was  expressed  from  the  appropri-
ate vector in each of four cell-free systems, made 
from  rabbit  reticulocyte,  wheat  germ,  insect  cell 
or E. coli extracts. The kinase was expressed as a 
HaloTag fusion protein with the tag at the amino-
terminus  or  carboxy-terminus.  Synthesis  of  the 
74 kDa fusion protein was confirmed by western 
blot analysis using antibodies specific for PKA and 
HaloTag protein. The blot probed with antibody to 
PKA is shown in Figure 3A. Similar results were 
obtained when the anti- HaloTag antibody was used 
(data not shown). Protein was detectable in all four 
systems, though expression levels varied between 
the  systems,  with  the  S30  producing  the  greatest 
amount of protein and the rabbit reticulocyte lysate 
system the least. Therefore, the protein from the RR 
system  was  more  easily  visualized  when  blotted 
separately from the S30 system to allow for longer 
development time (Fig. 4A). Both amino-terminal 
and carboxy-terminal fusion proteins were success-
fully expressed in three systems: the RR, ICE and 
WG systems. In the S30 system the HaloTag-cPKA 
was expressed as an amino-terminal fusion protein 
from the pFN18 vector, the vector recommended for 
use with this system. It was also expressed from the 
pFN19 vector, but not from the pFC20 vector (data 
not shown).
Protein  levels  were  also  assessed  using  a  fluo-
rescent assay specific for HaloTag protein. For this 
assay, the translation reactions were incubated with 
a TMR ligand specific for HaloTag protein. Cova-
lent  binding  of  the  ligand  to  the  HaloTag  fusion 
protein results in the attachment of one fluorescent 
label per protein molecule and makes it possible to 
assess protein expression levels when compared to 
labeled protein standards. The reactions were electro-
phoresed on polyacrylamide gels which were imaged 
to detect the fluorescent signal (Figs. 3B and 4B). The 
relative levels of the proteins agreed with the   ranking 
obtained  with  both  western  analyses.  Also,  using 
known amounts of purified GST-HaloTag protein as a 
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Figure 4. Detection of cPKA Fusion Proteins expressed in rr Before 
and After Immobilization. A) Western Blot Analysis. The amount of fusion 
protein before and after immobilization was determined by gel electro-
phoresis followed by immunoblotting with antibody specific for PKA at a 
1:1000 fold dilution. A volume equivalent to 1 µl of the protein synthesis 
reaction was loaded per lane. Lanes 1 and 2: no DnA template negative 
control reaction; Lanes 3 and 4: pFn19-cPKA; Lanes 5 and 6: pFC20-
cPKA. The starting materials from the TnT reactions are in lanes 1, 3 and 
5, and the post-immobilization supernatants (“flowthroughs”) are in lanes 
2, 4 and 6. B) haloTag TMr Ligand Binding Assay. The starting material 
and post-immobilization supernatants were incubated with haloTag TMr 
Ligand as indicated in the experimental section. A volume equivalent 
to 1 µl of the starting reaction was loaded per lane in the same lane 
order listed in Panel A. A comparison of protein levels in lanes 3 and 4, 
and lanes 5 and 6, is made to determine binding of the fusion protein 
to the magnetic beads. The arrow points to the expressed cPKA fusion 
protein.
standard, the concentration of protein was determined 
(Table 1). In addition to facilitating sensitive detec-
tion and measurement, the ligand-binding assay also 
served as a functional assay for the HaloTag portion 
of the fusion protein. The ability of the fusion protein 
to bind the fluorescent ligand provided evidence that 
the HaloTag part of the protein was expressed in an 
active form.
Immobilization and activity assay
cPKA  kinase  activity  was  assayed  using  the  Pro-
Fluor PKA Assay System, a fluorescent assay based 
on the phosphorylation of a rhodamine 110 peptide 
substrate. In the absence of phosphorylation the pep-
tide is proteolytically cleaved to release the highly 
fluorescent rhodamine 110; phosphorylation prevents 
this cleavage. Thus there is an inverse relationship 
between  the  fluorescent  signal  and  the  amount  of 
kinase present.
Before assaying for kinase activity, it was necessary 
to isolate the fusion protein from the cell-free reaction. 
This was accomplished by specific   immobilization 
onto HaloLink Magnetic Beads. These paramagnetic  Cell-Free kinase
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particles are chemically modified with chloroalkane, 
a substrate for HaloTag protein, to provide a solid 
support for covalent attachment of HaloTag fusion 
proteins.  To  assay  for  activity,  50  µl  of  protein 
synthesis reactions were incubated with the particles 
as described in the Experimental Section.
After the initial binding step, protein binding was 
verified by the lack of protein in the supernatant, as 
assessed by western blotting and TMR ligand bind-
ing (Fig. 4). In Figure 4 Panels A and B, the reduced 
amount of protein in lanes 4 and 6, as compared to 
lanes  3  and  5,  respectively,  indicate  the  success-
ful and efficient attachment of the fusion protein to 
the magnetic beads in the RR system. Comparison 
of the TMR fluorescent signal in the total reaction 
and the post-binding supernatant indicated that 90% 
of the fusion protein bound to the magnetic beads for 
all systems except the S30, where 80% bound (data 
not shown).
The particles were washed with binding and kinase 
buffers and then resuspended in 200 µl of kinase buf-
fer. The activity of the immobilized cPKA fusion pro-
tein was assayed in a 96-well plate by adding various 
volumes of particles per well and using the ProFlour 
PKA Assay. Activity was detected for the rabbit reticu-
locyte lysate, insect cell extract and wheat germ extract 
reactions (Table 2). The activity in the S30 reactions 
could not be assessed due to bead aggregation, most 
likely the result of extensive protein binding. Transla-
tion reactions that lacked DNA template served as the 
negative controls. Magnetic particles incubated with 
these negative control reactions showed the maximal 
fluorescent signal expected in the absence of kinase 
activity.  Wells  with  kinase  captured  on  particles 
had lower signals indicating the presence of kinase 
activity. The activity was highest for the insect cell 
and wheat germ expressed proteins. When 25 µl of 
particles from these reactions were added per well, 
the maximal amount of kinase activity detectable with 
the ProFluor PKA Assay was observed.
Inhibitor testing
After  determining  that  the  cell-free  expressed 
kinases were expressed and active, they were tested 
with  known  inhibitors  of  PKA.  The  HaloTag-
cPKA  N-  terminal  fusion  protein  expressed  in  the 
WG system was tested for its ability to be inhibited 
Table 1. estimated protein expression levels.
cell-free extract estimated protein 
concentration (ng/µl)
HaloTag® at 
n-terminus
HaloTag® at 
c-terminus
rabbit reticulocyte 5 3
Insect Cell 23 10
Wheat germ 83 65
E. coli s30 230 nD
The fusion protein concentration was estimated by comparing fluorescent 
signal emitted by haloTag TMr ligand bound to a known amount of 
haloTag-gsT fusion protein to the signal from the cell-free expressed 
HaloTag-cPKA  fusion  proteins.  One  molecule  of  fluorescent  HaloTag 
TMr ligand binds per protein, so the calculations were made based on 
the number of moles of protein and then converted to concentration in 
terms of mass. 
Abbreviation: nD: not done.
Table 2. ProFluor PKA activity assay.
extract Volume of 
particle solution 
(µl)
Fluorescent signal
no DnA HaloTag® at 
n-terminus
HaloTag® at 
c-terminus
rabbit reticulocyte 5
25
135447
105567
110315
65218
125433
91560
Insect Cell 5
25
97799
92087
26406
506
25442
476
Wheat germ 5
25
105628
84489
34406
656
28210
579
E. coli s30 5
25
119561
112126
nT
nT
nD
nD
cPKA fusion proteins were expressed in all four cell-free extracts. reactions without added DnA templates were used as negative controls. After 
immobilization of fusion protein onto magnetic particles, the particles were resuspended in 200 µl 1X Kinase Buffer. The indicated amount of particle 
solution was added per well for the kinase assay. All reactions were done in duplicate and the signal averaged. The fluorescent signal is inversely 
correlated with kinase activity. 
Abbreviations: nT: not tested. nD: not done.Leippe et al
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by 3 potent PKA inhibitors (i.e. Ki’s reportedly in low 
nM range) and one inhibitor, U0126, of an unrelated 
kinase (MEK) as a negative control. Two volumes 
of particles were tested, 10 µl and 20 µl. Also, as a 
positive activity control, two concentrations of highly 
purified recombinant bovine cAMP-dependent pro-
tein kinase catalytic subunit (rPKA) were included 
in the experiment. Inhibition was observed for both 
the cell-free expressed and recombinant protein upon 
incubation with the 3 potent inhibitors, but not with 
the  U0126  inhibitor  (Fig.  5).  The  HaloTag-cPKA 
N-terminal fusion protein expressed in the insect cell 
extract system was also similarly inhibited by these 
three inhibitors and additional known PKA inhibi-
tors of lesser potency (i.e. Ki’s reportedly in low µM 
range; Fig. 6). When the assay was carried out in the 
absence of added kinase or ATP, the fluorescent sig-
nal was maximal (Fig. 7 and data not shown). This 
demonstrated that reduced fluorescence was ATP and 
kinase dependent and not due to assay interference by 
the inhibitors (e.g. inhibition of the protease used in 
the ProFluor PKA Assay to cleave the unphosphory-
lated peptide).
Discussion
Protein expression and detection
Selection of a cell-free system to express a protein of 
interest is best determined empirically, therefore, the 
cPKA was tested in parallel in four different   cell-free 
systems to determine the optimal system(s) for this 
particular  study.  Expression  of  human  cPKA  was 
demonstrated in all four systems at levels within the 
expected range for each of the individual cell-free 
products.2,3,5,7 The cPKA was expressed as a HaloTag 
fusion protein, with the tag at either the amino- or 
carboxy-terminus, and the HaloTag functionality was 
used for the covalent capture of the kinase from the 
complex cell-free extract mixtures prior to activity 
analysis. Total protein expression was analyzed by 
using antibody against the cPKA or HaloTag proteins, 
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Figure 5. Inhibition of haloTag-cPKA expressed in Wheat germ extract. cPKA fusion protein expressed from pFn19 in Wheat germ extract was immo-
bilized onto magnetic beads and assayed for activity using the fluorescent ProFluor PKA Assay, in the presence of the kinase inhibitors H-89, PKI and 
staurosporine. The final concentration of inhibitor in the reaction was 10 µM. Two amounts of particle solution were used, 10 µl and 20 µl. The assay was 
also done with rPKA at two concentrations. As negative controls the kinase was incubated with Kinase Buffer (Buffer), DMSO (1% final concentration) or 
an inhibitor U0126 for an unrelated kinase. Each inhibitor was tested in duplicate and the average fluorescence is depicted. The bars represent the signal 
from each of the duplicate wells (i.e. the range). Cell-Free kinase
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and active HaloTag protein was detected by labeling 
with a fluorescent ligand. The latter method was also 
used for protein quantitiation, using a fluorescently 
labeled HaloTag protein of known concentration as a 
reference standard. Relative protein expression lev-
els were in agreement using both detection methods, 
suggesting the differences in HaloTag activity were 
due to expression levels not inactive protein. Fluores-
cent labeling was more sensitive in the RR   reactions 
and  more  specific  in  S30  reactions,  providing  an 
  advantage over immunoblotting.
Activity analysis
As components in the crude reaction mixtures inter-
fere  with  the  activity  assay  (data  not  shown),  the 
kinase was detected after specific immobilization on 
magnetic particles. The greatest activity was detected 
on particles bound with cPKA from the ICE and WG 
systems. The fluorescent signal from the ProFluor 
PKA assay was maximally reduced when 25 µl of 
particles  were  assayed,  indicating  the  presence  of 
kinase  activity  at  a  level  at  or  above  the  highest 
amount measurable by the assay. In contrast, 25 µl 
of particles from the RR reactions showed less activ-
ity. In this protocol, 100 µl of bead slurry was used 
to capture protein out of 50 µl of translation reaction. 
The manufacturer’s stated capacity of this volume of 
particles (200 µg fusion protein/100 µl slurry) has 
not been reached, so it may be possible to achieve 
higher activity by using the same amount of particles 
to capture fusion protein from a greater volume of 
rabbit reticulocyte translation reaction. On the other 
hand, after incubation with the S30 translation reac-
tions containing DNA template particles aggregated 
so  no  reliable  measurement  was  obtained. As  the 
aggregation was not observed with negative control 
reactions that did not express the fusion protein, this 
aggregation  was  most  likely  due  to  the  excessive 
amount of captured fusion protein. Our observation 
suggests that prior optimization of reaction volume 
to  particle  ratio  might  be  advantageous  in  these 
situations.
Kinase captured from the insect cell and wheat 
germ  extracts  was  active  at  levels  that  permitted 
easy and rapid assay. The kinase could be assayed 
directly on the magnetic particle and did not have to 
be released or further purified. The amount of activity 
was  similar  for  both  extracts  and  for  both  fusion 
orientations  (Table  2).  Since  more  fusion  protein 
was synthesized in the wheat germ system (Table 1), 
the specific activity (activity per mass) seemed to be 
higher for cPKA produced in the insect cell extract 
system. The insect cell extract is made from Sf21 
(Spodoptera frugiperda) cells, a cell line that often 
used  for  expression  of  large  quantities  of  soluble, 
active proteins.15 It will be interesting to see if this 
is also an advantage of the cell-free ICE system in 
future studies.
Inhibitor analysis
The cPKA fusion proteins with N-terminal HaloTag 
from two systems, the WG and ICE systems, were 
tested with and found to be inhibited by known PKA 
inhibitors.  The  same  inhibitors  were  also  demon-
strated to be active against the positive control protein, 
recombinant highly purified bovine PKA in solution. 
Therefore, the protein produced in and immobilized 
from cell-free systems was not just active, but exhib-
ited the expected biologically relevant activity. This 
suggested that the cell-free expressed protein kinase 
could  substitute  for  highly  purified  kinase  in  this 
application.
Initial  inhibition  experiments  were  done  with 
known  strong  PKA  inhibitors,  which  included  a 
peptide  inhibitor  PKI  (noncompetitive  with  ATP), 
a  competitive  inhibitor,  H-89,  with  specificity  for 
PKA, and a general kinase inhibitor, staurosporine 
(Figs. 5 and 6). When the inhibitor panel was then 
extended to include less potent inhibitors (Fig. 6), the 
assay was able to distinguish between inhibitors of 
higher and lower potencies. Therefore this approach 
might be used for small compound screening to iden-
tify inhibitors of unknown specificity and/or potency. 
To  identify  competitive  inhibitors  the  assay  could 
be done at increased and decreased ATP concentra-
tions; also at decreased ATP concentrations weaker 
inhibitors would be more effective.
Combining cell-free protein synthesis 
and haloTag technologies for functional 
protein analysis
In this paper, cell-free expression and HaloTag tech-
nologies were integrated and adapted to facilitate Leippe et al
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Figure 6. Inhibition of haloTag-cPKA expressed in Insect Cell extract. haloTag-cPKA protein was expressed from the pF25 n hT plasmid in the TnT T7 
Insect Cell extract. After immobilization, 5 µl of particle suspension were added per well of the 96 well plate. reactions containing positive control human 
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Figure 7. Dependence of the Kinase Signal on ATP. Control reactions for the ProFluor PKA Assay were done in the absence of ATP to confirm the depen-
dency of the signal on ATP and the lack of signal interference by components in the reactions. This figure shows the results for 1% DMSO and 10 µM 
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quick enzyme activity assays. The cell-free protein 
synthesis  systems  provided  quick  access  to  the 
  protein of interest while the HaloTag   technology 
provided efficient, covalent protein immobilization 
of the fusion protein, eliminating the need for further 
protein purification and minimizing storage-  related 
stability issues. Efficient capture of the protein of 
interest was critical when dealing with the lower 
concentrations  of  protein  that  can  be  present  in 
cell-free  systems  and  this  was  accomplished  by 
using the HaloTag technology. The covalent immo-
bilization ensured that the fusion protein was not 
lost during subsequent wash steps. Both of these 
features increased the amount of protein captured 
on particles and therefore available for the down-
stream  kinase  assay.  This  led  to  robust  signals 
and a reduction in the amount of material needed 
per assay.
As each of the technologies is not lengthy, data 
could  be  obtained  quickly.  The  cell-free  reactions 
were incubated one to four hours depending on the 
particular extract systems used. The immobilization 
step and subsequent washes proceeded for one hour. 
Assaying the fusion protein while still bound to the 
particles eliminated the need to cleave the kinase from 
the  HaloTag  protein.  The  particular  activity  assay 
used in these experiments, the ProFluor PKA Assay 
required 1.5 hours. Therefore, the method allows all 
steps be completed in the same day, from protein syn-
thesis to activity measurement.
These results demonstrate the feasibility of using 
cell-free expression and immobilization technologies 
for rapid activity screening when purified enzyme is 
not available or necessary. It is being used to confirm 
the synthesis of other active kinases in the ICE system 
(data not shown) and the process should be adaptable 
to proteins other than kinases as well. The approach 
will be also useful to rapidly produce, capture and 
screen several different proteins, or their variants, in 
parallel without having to purify large numbers of 
proteins.
conclusions
This article describes an approach for expressing func-
tional proteins in cell-free systems for downstream 
activity analysis. The addition of a fusion tag, the 
HaloTag protein, allowed for efficient immobilization 
directly from the protein synthesis reaction and the 
subsequent activity assay of the immobilized protein. 
In this way, the catalytic subunit of human cAMP-
dependent protein kinase was shown to be expressed 
in an active form and to be inhibited by known PKA 
inhibitory  compounds.  The  combination  of  these 
rapid protein synthesis and capture technologies facil-
itated and simplified the process of protein expression 
and activity screening. The “on-demand” synthesis 
and purification may provide an alternative to exten-
sive protein purification and the stability issues that 
can accompany long-term storage of the purified pro-
tein. This could offer an advantage especially when 
multiple proteins or variants need to be produced and 
assayed.
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